I understand from their last announcement that there may be a drop in revenue which will obviously put pressure on profit.Despite this, the stock does some well undervalued at its current price.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025